首页> 美国卫生研究院文献>Viruses >Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1
【2h】

Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1

机译:非保守抗体介导针对HIV-1的有效ADCC的高度保守的env表位的构象性掩蔽和依赖受体的解蔽。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The mechanism of antibody-mediated protection is a major focus of HIV-1 vaccine development and a significant issue in the control of viremia. Virus neutralization, Fc-mediated effector function, or both, are major mechanisms of antibody-mediated protection against HIV-1, although other mechanisms, such as virus aggregation, are known. The interplay between virus neutralization and Fc-mediated effector function in protection against HIV-1 is complex and only partially understood. Passive immunization studies using potent broadly neutralizing antibodies (bnAbs) show that both neutralization and Fc-mediated effector function provides the widest dynamic range of protection; however, a vaccine to elicit these responses remains elusive. By contrast, active immunization studies in both humans and non-human primates using HIV-1 vaccine candidates suggest that weakly neutralizing or non-neutralizing antibodies can protect by Fc-mediated effector function, albeit with a much lower dynamic range seen for passive immunization with bnAbs. HIV-1 has evolved mechanisms to evade each type of antibody-mediated protection that must be countered by a successful AIDS vaccine. Overcoming the hurdles required to elicit bnAbs has become a major focus of HIV-1 vaccine development. Here, we discuss a less studied problem, the structural basis of protection (and its evasion) by antibodies that protect only by potent Fc-mediated effector function.
机译:抗体介导的保护机制是HIV-1疫苗开发的主要重点,也是控制病毒血症的重要问题。病毒中和,Fc介导的效应子功能或两者是抗体介导的针对HIV-1的保护的主要机制,尽管其他机制(例如病毒聚集)也是已知的。病毒中和与Fc介导的效应子功能在针对HIV-1的保护中的相互作用是复杂的,只有部分被理解。使用有效的广泛中和抗体(bnAbs)进行的被动免疫研究表明,中和和Fc介导的效应子功能均提供了最大的动态保护范围。然而,引起这些反应的疫苗仍然难以捉摸。相比之下,在人类和非人类灵长类动物中使用HIV-1候选疫苗进行的主动免疫研究表明,弱中和或非中和抗体可以通过Fc介导的效应子功能进行保护,尽管被动免疫接种的动态范围低得多bnAbs。 HIV-1已经发展出逃避每种抗体介导的保护作用的机制,而成功的AIDS疫苗必须对付这种保护作用。克服引发bnAb所需的障碍已成为HIV-1疫苗开发的主要重点。在这里,我们讨论了一个鲜为人知的问题,即仅受有效Fc介导的效应子功能保护的抗体的保护作用(及其逃避作用)的结构基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号